Compartmental Analyses of 2H5-alpha-linolenic Acid and C-U-eicosapentaenoic Acid Toward Synthesis of Plasma Labeled 22:6n-3 in Newborn Term Infants
Overview
Affiliations
Background: During early postnatal development, the nervous system accretes docosahexaenoic acid (DHA; 22:6n-3), a highly unsaturated n-3 (omega-3) fatty acid (FA) used in the formation of neural cell membranes. DHA, which is present in human breast milk, may also be biosynthesized from n-3 FAs such as 18:3n-3 [alpha-linolenic acid (ALA)] or 20:5n-3 [eicosapentaenoic acid (EPA)]. An important concern is to what extent these precursors can supply DHA to the developing infant.
Objective: We analyzed measurements of fractional percentages of plasma (2)H(5)-ALA and (13)C-U-EPA directed toward the synthesis of labeled 22:6n-3 in 11 newborn infants by using compartmental modeling procedures.
Design: One-week-old infants received doses of (2)H(5)-ALA and (13)C-U-EPA ethyl esters enterally. We drew blood from the infants periodically and analyzed the plasma for endogenous and labeled n-3 FAs. From the time-course concentrations of the labeled FAs, we determined rate constant coefficients, fractional synthetic rates, and plasma turnover rates of n-3 FAs.
Results: In infants, approximately 0.04% of the (2)H(5)-ALA dose converted to plasma (2)H(5)-EPA. Plasma (2)H(5)-EPA and (2)H(5)-22:5n-3 [docosapentaenoic acid (DPA)] efficiently converted to (2)H(5)-DPA and (2)H(5)-DHA, respectively. The percentage of plasma (13)C-U-EPA directed toward the synthesis of (13)C-DHA was lower than the percentage of plasma (2)H(5)-EPA that originated from (2)H(5)-ALA.
Conclusions: Endogenously synthesized EPA was efficiently converted to DHA. In comparison, preformed EPA was less efficiently used for DHA biosynthesis, which suggests a differential metabolism of endogenous EPA compared with exogenous EPA. However, on a per mole basis, preformed EPA was 3.6 times more effective toward DHA synthesis than was ALA. Newborns required an intake of approximately 5 mg preformed DHA. kg(-1) x d(-1) to maintain plasma DHA homeostasis.
Manuela S, Simonato M, Verlato G, Giovanna V, Visentin S, Silvia V Br J Nutr. 2024; 133(2):194-201.
PMID: 39679455 PMC: 11813620. DOI: 10.1017/S0007114524003222.
Centorame G, Warrington N, Hemani G, Wang G, Davey Smith G, Evans D Behav Genet. 2024; 55(2):86-102.
PMID: 39652205 PMC: 11882634. DOI: 10.1007/s10519-024-10210-0.
Ouagueni A, Al-Zoubi R, Zarour A, Al-Ansari A, Bawadi H Mar Drugs. 2024; 22(5).
PMID: 38786598 PMC: 11123418. DOI: 10.3390/md22050207.
Dietary Implications of Polyunsaturated Fatty Acids during Pregnancy and in Neonates.
Herrera E, Ortega-Senovilla H Life (Basel). 2023; 13(8).
PMID: 37629513 PMC: 10455977. DOI: 10.3390/life13081656.
Prado-Cabrero A, Nolan J Ambio. 2021; 50(6):1184-1199.
PMID: 33502683 PMC: 8068752. DOI: 10.1007/s13280-020-01472-z.